302058新竹縣竹北市生醫路二段6號3樓R310
R310,3F, No. 6, Sec. 2, Shengyi Rd., Zhubei City, Hsinchu County 302058, Taiwan (R.O.C.)
R&D plan
PETCONGEL
Product Overview
This is an injectable gel that combines hemostatic and drug-release capabilities, showing significant effects on volatile anticancer agents. Its injectability makes it particularly suitable for treating large and residual lesions after surgery. This product addresses the challenge of treating highly aggressive pet cancers that cannot be effectively managed through conventional chemotherapy.
Product Description
An injectable drug-loaded gel for precision treatment of aggressive tumors in pets.
Advantage
優勢
▶︎ Carries hydrophobic anti-cancer drugs – Directly mixing with hydrophobic drugs
▶︎ Reduces wound bleeding – Minimizing the risk of infection
▶︎ Injectable hydrogel – Reduces systemic side effects
▶︎ Bioabsorbable – Completely absorbed within two days
Product Features
產品特性
▶︎ No changes in temperature or pH levels
▶︎ The gel can extend the activity of hydrophobic anticancer drugs to 48 hours
▶︎ Injectability and viscosity
▶︎ In situ gelation and reduced bleeding
▶︎ Completely absorbed within 48 hours, eliminating need to clean residual gel during dressing changes
▶︎ No bleeding or signs of infection observed after two weeks of administration
Competitive Advantage
競爭優勢
▶︎ Suitable for the treatment of highly aggressive tumors
▶︎ Low dosage of the drug
▶︎ Convenient wound care
▶︎ Cancer recurrence rate